MetaCap

Axonex AI Group (AXNX) vs Baosheng Media Group (BAOS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Axonex AI Group is the larger company by market cap ($5.3 million vs $3.9 million), about 1.4 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AXNX+16.92%BAOS-44.10%
+64%+8%-49%
Oct 13, 20261 yearNov 20, 2026
AXNX+76.17%BAOS-35.62%
+135%+46%-44%
Oct 12, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AXNX versus BAOS key metrics
MetricAXNXBAOS
Share price$0.8301$0.1166
Market cap$5.28M$3.89M
1-day change-8.28%-8.91%
EPS (TTM)$-10.37$-9.01
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$568.99K
Revenue growth (YoY)—-8.83%
Net income (latest FY)$-10.31M$-12.02M
Gross margin—12.55%
Operating margin—-1799.37%
Net margin—-2112.79%
52-week high$18.35$3.82
52-week low$0.68$0.11
Distance from 52-week high-95.48%-96.95%
Analyst consensushold—
Average volume2.01M3.12M
Shares outstanding6.08M33.37M
Employees79726
SectorConsumer DiscretionaryConsumer Discretionary
IndustryBusiness ServicesBusiness Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Axonex AI Group

AXNX stock →

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI.

Consumer Discretionary · Business Services · 797 employees

About Baosheng Media Group

BAOS stock →

Baosheng Media Group Holdings Limited, an offshore holding company, operates as an online marketing solution provider in the People's Republic of China. It connects advertisers, online media, and helping advertisers to manage their online marketing activities in various ways, including advising on advertising strategies, budget and choice of advertising channels; procures ad inventory; offers ad optimization services; and administrates and fine-tunes the ad placement process.

Consumer Discretionary · Business Services · 26 employees

AXNX vs BAOS FAQ

Which is bigger, Axonex AI Group or Baosheng Media Group?

Axonex AI Group (AXNX) is larger, with a market capitalization of $5.28M compared with $3.89M for Baosheng Media Group (BAOS).

Are Axonex AI Group and Baosheng Media Group in the same industry?

Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.

More comparisons